Progesterone does not cause hot flashes. In fact, clinical evidence shows the opposite: progesterone, particularly in its oral micronized form, can reduce hot flashes and night sweats. The confusion likely stems from the fact that falling progesterone levels during perimenopause coincide with the onset of hot flashes, which makes the hormone seem like the culprit when it’s actually the loss of it that contributes to the problem.
Why Falling Progesterone Triggers Hot Flashes
Your body’s internal thermostat lives in a region of the brain called the hypothalamus. It maintains a narrow comfort zone, and when your core temperature drifts outside that zone, the brain triggers cooling responses like sweating, flushing, and blood vessel dilation. Estrogen and progesterone both influence how wide or narrow that comfort zone is.
Estrogen generally promotes heat dissipation and lowers body temperature, while progesterone has a mild warming effect and helps stabilize the thermoregulatory set point. During perimenopause, estrogen levels swing unpredictably and progesterone production drops as ovulation becomes less frequent. These hormonal swings narrow the thermoregulatory zone, meaning even tiny changes in core temperature can set off a hot flash. It’s the instability and decline of both hormones, not their presence, that destabilizes the system.
What the Clinical Trials Show
Multiple randomized controlled trials have tested oral micronized progesterone specifically for hot flashes. The largest study using 300 mg of oral micronized progesterone found a 58.9% improvement in vasomotor symptoms, compared to just 23.5% in the placebo group. A more recent multi-center trial tested three doses (200 mg, 300 mg, and 400 mg) over 12 weeks and found a slight dose-dependent improvement across all groups, with the 400 mg group seeing the greatest reduction in moderate to severe hot flashes.
A Phase III Canadian trial focused on perimenopausal women found that those taking progesterone perceived significantly greater decreases in night sweats compared to placebo. Notably, hot flashes were not listed among the side effects of progesterone in any of these trials. The only adverse event potentially linked to the hormone in blinded review was occasional dizziness.
Progesterone Withdrawal and Rebound Effects
One reason people associate progesterone with hot flashes may be concerns about what happens when you stop taking it. The evidence here is reassuring. When postmenopausal women abruptly discontinued progesterone in clinical studies, there was no rapid increase in hot flashes over the following month. This contrasts sharply with estrogen-based hormone therapy, where stopping treatment caused about a quarter of women to experience clinically significant rebound hot flashes. Progesterone appears to exit the system without triggering a flare.
Oral Progesterone vs. Transdermal Progesterone
Not all forms of progesterone work equally well for hot flashes. Oral micronized progesterone, taken as a capsule, has the strongest evidence for reducing vasomotor symptoms. Transdermal progesterone (applied as a cream or gel) has not shown the same benefit. The largest study testing transdermal progesterone, involving 230 women, reported no improvement in hot flashes compared to placebo. This difference likely comes down to how much progesterone actually reaches the bloodstream and brain through each delivery method.
It’s also worth distinguishing between bioidentical progesterone and synthetic progestins like medroxyprogesterone acetate. Synthetic progestins bind to the progesterone receptor differently and can activate other hormone receptors in various tissues, which changes their effect profile. Bioidentical micronized progesterone is chemically identical to the progesterone your body produces and is available in FDA-approved formulations. Many clinicians prefer it for this reason, though some synthetic progestins have also shown benefits for hot flashes in smaller studies.
How Progesterone Fits Into the Bigger Picture
During the menopause transition, hot flashes are driven primarily by wide swings in estrogen combined with less frequent progesterone production as cycles become anovulatory. Research tracking perimenopausal women found that greater estradiol variability, higher levels of follicle-stimulating hormone, and the presence of anovulatory cycles (when no egg is released and progesterone stays low) all contribute to symptom burden. Ovulatory cycles with more stable estrogen levels were associated with fewer symptoms.
This means progesterone plays a stabilizing role. When it’s present at adequate levels, the hormonal environment is calmer and the thermoregulatory system functions more normally. When it drops out, as it does increasingly during perimenopause, the body loses one of its tools for maintaining temperature equilibrium. Supplementing with oral progesterone essentially restores some of that stability, which is why it can reduce both daytime hot flashes and nighttime sweats.
For women who cannot or prefer not to take estrogen, progesterone-only treatment offers a meaningful alternative. While estrogen remains the most effective single treatment for severe hot flashes, the nearly 59% improvement seen with oral micronized progesterone in the largest trial puts it well above placebo and makes it a viable option on its own.